126 related articles for article (PubMed ID: 7525292)
1. Expression of AgNORs in serous ovarian tumors.
Trabucco S; Varcaccio-Garofalo G; Botticella MA; De Stefano R; Capursi T; Resta L
Eur J Gynaecol Oncol; 1994; 15(3):222-9. PubMed ID: 7525292
[TBL] [Abstract][Full Text] [Related]
2. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P
Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
[TBL] [Abstract][Full Text] [Related]
4. [Heterogeneity of ovarian epithelial tumors in analysis of nucleolar organizer regions (NORs) expression].
Terlikowski S; Lenczewski A; Sulkowska M; Famulski W; Sulkowski S; Musiatowicz B; Kulikowski M
Ginekol Pol; 2000 Sep; 71(9):1194-7. PubMed ID: 11083002
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions in ovarian tumors: discrimination between carcinoma and borderline tumor.
Khattech A; Spatz A; Prade M; Duvillard P; Charpentier P; Bognel C; Michel G; Lhommé C
Int J Gynecol Pathol; 1992; 11(1):11-4. PubMed ID: 1373413
[TBL] [Abstract][Full Text] [Related]
6. AgNOR distribution in serous tumours of the ovary.
Mauri FA; Scampini S; Aldovini D; Ferrero S; Barbareschi M; Dalla Palma P
Pathologica; 1990; 82(1081):487-92. PubMed ID: 1706828
[TBL] [Abstract][Full Text] [Related]
7. Expression of nucleolar organizer regions (NORs) in ovarian epithelial tumors.
Terlikowski S; Lenczewski A; Famulski W; Sulkowski S; Kulikowski M
Folia Histochem Cytobiol; 2001; 39(2):161-2. PubMed ID: 11374805
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
[TBL] [Abstract][Full Text] [Related]
9. [Nucleolus organizers in the epithelium of serous ovarian tumors].
Iakovtsova II
Tsitol Genet; 1995; 29(5):38-41. PubMed ID: 8721844
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
12. Nuclear morphometry and AgNOR quantification: computerized image analysis on ovarian mucinous tumor imprints.
Versa-Ostojić D; Stanković T; Stemberger-Papić S; Vrdoljak-Mozetic D; Manestar M; Krasević M
Anal Quant Cytol Histol; 2008 Jun; 30(3):160-8. PubMed ID: 18630841
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors.
Criscuolo M; Martinelli AM; Migaldi M; Zunarelli E; Bergamaschi M; Falchi AM; De Gaetani C
Int J Gynecol Pathol; 1993 Jul; 12(3):259-63. PubMed ID: 8344763
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
Plate KH; Rüschoff J; Mennel HD
Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
[TBL] [Abstract][Full Text] [Related]
15. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
[TBL] [Abstract][Full Text] [Related]
16. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
Rüschoff J
Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
[TBL] [Abstract][Full Text] [Related]
17. Pathology of borderline (low malignant potential) ovarian tumours.
Seidman JD; Ronnett BM; Kurman RJ
Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):499-512. PubMed ID: 12413931
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland tumours studied by means of the AgNOR technique.
Morgan DW; Crocker J; Watts A; Shenoi PM
Histopathology; 1988 Nov; 13(5):553-9. PubMed ID: 2463964
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organising regions in cervical intraepithelial neoplasia.
Rowlands DC
J Clin Pathol; 1988 Nov; 41(11):1200-2. PubMed ID: 2463271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
